BLOOMBERG.COM
'ai drug lab'

Nvidia to invest $1B in AI drug laboratory with Eli Lilly

SUMMARY

Nvidia is building a facility in Silicon Valley to enhance drug discovery through AI. This joint investment aims to expedite lab processes that currently depend on human researchers.

Nvidia sees potential in healthcare, where AI can automate experiments. Kimberly Powell, Nvidia’s VP, stated, “Humans are the primary constraint on the speed of labs.”

The lab will train AI engineers in lab operations and refine AI software for drug development. Nvidia is also expanding its AI models for healthcare and collaborating with Thermo Fisher to automate lab equipment.

This partnership positions Lilly at the cutting edge of AI in drug discovery, with plans to collaborate closely with Nvidia.


▶︎ Click here for more breaking news